Clinical trials
Phase 1 Carcinoma, Non-Small-Cell Lung trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
1,300 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 17 |
| 2001 | 11 |
| 2002 | 12 |
| 2003 | 17 |
| 2004 | 19 |
| 2005 | 26 |
| 2006 | 22 |
| 2007 | 41 |
| 2008 | 36 |
| 2009 | 46 |
| 2010 | 39 |
| 2011 | 33 |
| 2012 | 27 |
| 2013 | 42 |
| 2014 | 41 |
| 2015 | 56 |
| 2016 | 68 |
| 2017 | 61 |
| 2018 | 72 |
| 2019 | 72 |
| 2020 | 65 |
| 2021 | 78 |
| 2022 | 82 |
| 2023 | 69 |
| 2024 | 86 |
| 2025 | 77 |
| 2026 | 51 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 570 |
| Terminated | 268 |
| Recruiting | 178 |
| Active, not recruiting | 104 |
| Unknown status | 88 |
| Withdrawn | 47 |
| Not yet recruiting | 38 |
| Suspended | 5 |
| Enrolling by invitation | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 49 |
| Pfizer | 40 |
| Novartis Pharmaceuticals | 32 |
| AstraZeneca | 31 |
| Eli Lilly and Company | 27 |
| Boehringer Ingelheim | 21 |
| AbbVie | 20 |
| M.D. Anderson Cancer Center | 19 |
| Roswell Park Cancer Institute | 18 |
| Merck Sharp & Dohme LLC | 16 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 1,300 |
| Lung Neoplasms | 307 |
| Colorectal Neoplasms | 228 |
| Melanoma | 192 |
| Neoplasms | 183 |
| Breast Neoplasms | 165 |
| Ovarian Neoplasms | 161 |
| Squamous Cell Carcinoma of Head and Neck | 157 |
| Carcinoma, Renal Cell | 139 |
| Neoplasm Metastasis | 131 |
Trials
Showing 1 to 25 of 1,300. Each trial links to its page on Pharma Observatory.
1,200 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.